Environmental and Microbial Factors in Inflammatory Bowel Disease Model Establishment: A Review Partly through Mendelian Randomization

키워드

참고문헌 (169)

1. Kaplan GG, "The four epidemiological stages in the global evolution of inflammatory bowel disease", Nat Rev Gastroenterol Hepatol, 18, pp.56~66 (2021)
2. Ananthakrishnan AN, "Epidemiology and risk factors for IBD", Nat Rev Gastroenterol Hepatol, 12, pp.205~217 (2015)
3. Ananthakrishnan AN, "Environmental triggers in IBD : a review of progress and evidence", Nat Rev Gastroenterol Hepatol, 15, pp.39~49 (2018)
4. Piovani D, "Environmental risk factors for inflammatory bowel diseases : an umbrella review of meta-analyses", Gastroenterology, 157, pp.647~659 (2019)
5. Schirmer M, "Microbial genes and pathways in inflammatory bowel disease", Nat Rev Microbiol, 17, pp.497~511 (2019)
6. Zheng D, "Interaction between microbiota and immunity in health and disease", Cell Res, 30, pp.492~506 (2020)
7. Lynch SV, "The human intestinal microbiome in health and disease", N Engl J Med, 375, pp.2369~2379 (2016)
8. Agrawal M, "Multiomics to elucidate inflammatory bowel disease risk factors and pathways", Nat Rev Gastroenterol Hepatol, 19, pp.399~409 (2022)
9. de Souza HSP, "The IBD interactome : an integrated view of aetiology, pathogenesis and therapy", Nat Rev Gastroenterol Hepatol, 14, pp.739~749 (2017)
10. Schirmer M, "Dynamics of metatranscription in the inflammatory bowel disease gut microbiome", Nat Microbiol, 3, pp.337~346 (2018)
11. Sanderson E, "Mendelian randomization", Nat Rev Methods Primers, 2, pp.6~ (2022)
12. Davey Smith G, "Mendelian randomization : genetic anchors for causal inference in epidemiological studies", Hum Mol Genet, 23, pp.R89~R98 (2014)
13. Neeland IJ, "Mendelian randomization : using natural genetic variation to assess the causal role of modifiable risk factors in observational studies", Circulation, 135, pp.755~758 (2017)
14. Lewis JD, "Diet as a trigger or therapy for inflammatory bowel diseases", Gastroenterology, 152, pp.398~414 (2017)
15. Paik J, "High-fat diet-induced obesity exacerbates inflammatory bowel disease in genetically susceptible Mdr1a-", -male mice, 2013, pp.143, 1240~1247
16. Hou Y, "Comparison and recommendation of dietary patterns based on nutrients for Eastern and Western patients with inflammatory bowel disease", Front Nutr, 9, pp.1066252~ (2022)
17. Schmitz G, "The opposing effects of n-3 and n-6 fatty acids", Prog Lipid Res, 47, pp.147~155 (2008)
18. Scaioli E, "The imbalance between n-6", n-3 polyunsaturated fatty acids and inflammatory bowel disease : a comprehensive review and future therapeutic perspectives, 2017, pp.18, 2619~
19. Devkota S, "Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-", -mice, 2012, pp.487, 104~108
20. Lee JY, "High-fat diet and antibiotics cooperatively impair mitochondrial bioenergetics to trigger dysbiosis that exacerbates pre-inflammatory bowel disease", Cell Host Microbe, 28, pp.273~284 (2020)
21. Jantchou P, "Animal protein intake and risk of inflammatory bowel disease : the E3N prospective study", Am J Gastroenterol, 105, pp.2195~2201 (2010)
22. Mahalhal A, "Long-term iron deficiency and dietary iron excess exacerbate acute dextran sodium sulphate-induced colitis and are associated with significant dysbiosis", Int J Mol Sci, 22, pp.3646~ (2021)
23. Weiss G, "Iron in the inflammed gut : another pro-inflammatory hit?", Gut, 60, pp.287~288 (2011)
24. Ijssennagger N, "Sulfide as a mucus barrier-breaker in inflammatory bowel disease?", Trends Mol Med, 22, pp.190~199 (2016)
25. Albenberg L, "A diet low in red and processed meat does not reduce rate of Crohn’s disease flares", Gastroenterology, 157, pp.128~136 (2019)
26. Laffin M, "A high-sugar diet rapidly enhances susceptibility to colitis via depletion of luminal short-chain fatty acids in mice", Sci Rep, 9, pp.12294~ (2019)
27. Montrose DC, "Dietary fructose alters the composition, localization, and metabolism of gut microbiota in association with worsening colitis", Cell Mol Gastroenterol Hepatol, 11, pp.525~550 (2021)
28. Kawabata K, "A high‑fructose diet induces epithelial barrier dysfunction and exacerbates the severity of dextran sulfate sodium‑induced colitis", Int J Mol Med, 43, pp.1487~1496 (2019)
29. Deehan EC, "Modulation of the gastrointestinal microbiome with nondigestible fermentable carbohydrates to improve human health", Microbiol Spectr, 5, pp.BAD-0019-2017.~ (2017)
30. Deehan EC, "The fiber gap and the disappearing gut microbiome : implications for human nutrition", Trends Endocrinol Metab, 27, pp.239~242 (2016)
31. Sonnenburg ED, "Diet-induced extinctions in the gut microbiota compound over generations", Nature, 529, pp.212~215 (2016)
32. Ananthakrishnan AN, "Zinc intake and risk of Crohn’s disease and ulcerative colitis : a prospective cohort study", Int J Epidemiol, 44, pp.1995~2005 (2015)
33. Siva S, "Zinc deficiency is associated with poor clinical outcomes in patients with inflammatory bowel disease", Inflamm Bowel Dis, 23, pp.152~157 (2017)
34. Cho JM, "Hair mineral and trace element contents as reliable markers of nutritional status compared to serum levels of these elements in children newly diagnosed with inflammatory bowel disease", Biol Trace Elem Res, 185, pp.20~29 (2018)
35. Choi EK, "Impact of dietary manganese on experimental colitis in mice", FASEB J, 34, pp.2929~2943 (2020)
36. Han YM, "Risk factors for vitamin D, zinc, and selenium deficiencies in Korean patients with inflammatory bowel disease", Gut Liver, 11, pp.363~369 (2017)
37. Vaghari-Tabari M, "Zinc and selenium in inflammatory bowel disease : trace elements with key roles?", Biol Trace Elem Res, 199, pp.3190~3204 (2021)
38. Pineton de Chambrun G, "Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice", Mucosal Immunol, 7, pp.589~601 (2014)
39. de Bruyn JR, "Vitamin D deficiency in Crohn's disease and healthy controls : a prospective case-control study in the Netherlands", J Crohns Colitis, 8, pp.1267~1273 (2014)
40. Schardey J, "Vitamin D inhibits pro-inflammatory T cell function in patients with inflammatory bowel disease", J Crohns Colitis, 13, pp.1546~1557 (2019)
41. Chassaing B, "Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation", Gut, 66, pp.1414~1427 (2017)
42. Hajam IA, "Bacterial flagellin-a potent immunomodulatory agent", Exp Mol Med, 49, pp.e373~ (2017)
43. Nickerson KP, "The dietary polysaccharide maltodextrin promotes Salmonella survival and mucosal colonization in mice", PLoS One, 9, pp.e101789~ (2014)
44. Nickerson KP, "Crohn's disease-associated adherent-invasive Escherichia coli adhesion is enhanced by exposure to the ubiquitous dietary polysaccharide maltodextrin", PLoS One, 7, pp.e52132~ (2012)
45. Ruiz PA, "Titanium dioxide nanoparticles exacerbate DSS-induced colitis : role of the NLRP3 inflammasome", Gut, 66, pp.1216~1224 (2017)
46. Kish L, "Environmental particulate matter induces murine intestinal inflammatory responses and alters the gut microbiome", PLoS One, 8, pp.e62220~ (2013)
47. Elten M, "Ambient air pollution and the risk of pediatric-onset inflammatory bowel disease : a population-based cohort study", Environ Int, 138, pp.105676~ (2020)
48. Opstelten JL, "Exposure to ambient air pollution and the risk of inflammatory bowel disease : a European nested case-control study", Dig Dis Sci, 61, pp.2963~2971 (2016)
49. Ding S, "Association between exposure to air pollutants and the risk of inflammatory bowel diseases visits", Environ Sci Pollut Res Int, 29, pp.17645~17654 (2022)
50. Blachier F, "Cysteine-derived hydrogen sulfide and gut health : a matter of endogenous or bacterial origin", Curr Opin Clin Nutr Metab Care, 22, pp.68~75 (2019)
51. Dashdorj A, "Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines", BMC Med, 11, pp.178~ (2013)
52. Niedzwiecki MM, "The exposome : molecules to populations", Annu Rev Pharmacol Toxicol, 59, pp.107~127 (2019)
53. Sies H, "Reactive oxygen species(ROS)as pleiotropic physiological signalling agents", Nat Rev Mol Cell Biol, 21, pp.363~383 (2020)
54. Bhattacharyya A, "Oxidative stress : an essential factor in the pathogenesis of gastrointestinal mucosal diseases", Physiol Rev, 94, pp.329~354 (2014)
55. Singh V, "Balancing reactive oxygen species generation by rebooting gut microbiota", J Appl Microbiol, 132, pp.4112~4129 (2022)
56. AlQasrawi D, "Divergent effect of cigarette smoke on innate immunity in inflammatory bowel disease : a nicotine-infection interaction", Int J Mol Sci, 21, pp.5801~ (2020)
57. Zhao Y, "MicroRNA-124 promotes intestinal inflammation by targeting aryl hydrocarbon receptor in Crohn's disease", J Crohns Colitis, 10, pp.703~712 (2016)
58. Sun Y, "MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines", Cell Res, 23, pp.1270~1283 (2013)
59. AlQasrawi D, "Mystery solved : why smoke extract worsens disease in smokers with Crohn's disease and not ulcerative colitis?", Gut MAP! Microorganisms, 8, pp.666~ (2020)
60. Xia B, "Regular use of proton pump inhibitor and the risk of inflammatory bowel disease : pooled analysis of 3 prospective cohorts", Gastroenterology, 161, pp.1842~1852 (2021)
61. Aparecida Dos Reis Louzano S, "Ceftriaxone causes dysbiosis and changes intestinal structure in adjuvant obesity treatment", Pharmacol Rep, 74, pp.111~123 (2022)
62. Ungaro R, "Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis : a meta-analysis", Am J Gastroenterol, 109, pp.1728~1738 (2014)
63. Sanidad KZ, "Triclosan and triclocarban as potential risk factors of colitis and colon cancer : roles of gut microbiota involved", Sci Total Environ, 842, pp.156776~ (2022)
64. Pierdominici M, "Linking estrogen receptor β expression with inflammatory bowel disease activity", Oncotarget, 6, pp.40443~40451 (2015)
65. Ortizo R, "Exposure to oral contraceptives increases the risk for development of inflammatory bowel disease : a metaanalysis of case-controlled and cohort studies", Eur J Gastroenterol Hepatol, 29, pp.1064~1070 (2017)
66. Sun W, "Tonsillectomy and the risk of inflammatory bowel disease : a systematic review and metaanalysis", J Gastroenterol Hepatol, 31, pp.1085~1094 (2016)
67. Palomares O, "Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance", J Allergy Clin Immunol, 129, pp.510~520 (2012)
68. Huang H, "Is IgA nephropathy induced by abnormalities of CD4+CD25+Treg cells in the tonsils?", Med Hypotheses, 69, pp.410~413 (2007)
69. Powrie F, "Control of immune pathology by regulatory T cells", Novartis Found Symp, 252, pp.92~114 (2003)
70. Kaplan GG, "The risk of developing Crohn's disease after an appendectomy : a meta-analysis", Am J Gastroenterol, 103, pp.2925~2931 (2008)
71. Ng SC, "Geographical variability and environmental risk factors in inflammatory bowel disease", Gut, 62, pp.630~649 (2013)
72. Hansen TS, "Environmental factors in inflammatory bowel disease : a case-control study based on a Danish inception cohort", J Crohns Colitis, 5, pp.577~584 (2011)
73. Andersson RE, "Appendectomy and protection against ulcerative colitis", N Engl J Med, 344, pp.808~814 (2001)
74. Baron S, "Environmental risk factors in paediatric inflammatory bowel diseases : a population based case control study", Gut, 54, pp.357~363 (2005)
75. Chung WS, "Risk of inflammatory bowel disease following appendectomy in adulthood", Front Med(Lausanne), 8, pp.661752~ (2021)
76. Roblin X, "Local appendiceal dysbiosis : the missing link between the appendix and ulcerative colitis?", Gut, 61, pp.635~636 (2012)
77. Vitetta L, "The vermiform appendix : an immunological organ sustaining a microbiome inoculum", Clin Sci(Lond), 133, pp.1~8 (2019)
78. Cheluvappa R, "A novel model of appendicitis and appendectomy to investigate inflammatory bowel disease pathogenesis and remediation", Biol Proced Online, 16, pp.10~ (2014)
79. Cheluvappa R, "Identification of new potential therapies for colitis amelioration using an appendicitis-appendectomy model", Inflamm Bowel Dis, 25, pp.436~444 (2019)
80. Cheluvappa R, "Autophagy suppression by appendicitis and appendectomy protects against colitis", Inflamm Bowel Dis, 20, pp.847~855 (2014)
81. Cheluvappa R, "T helper type 17 pathway suppression by appendicitis and appendectomy protects against colitis", Clin Exp Immunol, 175, pp.316~322 (2014)
82. Ruan W, "Healthy human gastrointestinal microbiome : composition and function after a decade of exploration", Dig Dis Sci, 65, pp.695~705 (2020)
83. Sartor RB, "Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches", Gastroenterology, 152, pp.327~339 (2017)
84. Nikou SA, "Candida albicans interactions with mucosal surfaces during health and disease", Pathogens, 8, pp.53~ (2019)
85. Li XV, "Immune regulation by fungal strain diversity in inflammatory bowel disease", Nature, 603, pp.672~678 (2022)
86. Duan Y, "Bacteriophages and their potential for treatment of gastrointestinal diseases", Nat Rev Gastroenterol Hepatol, 19, pp.135~144 (2022)
87. Hedžet S, "Broad host range may be a key to long-term persistence of bacteriophages infecting intestinal Bacteroidaceae species", Sci Rep, 12, pp.21098~ (2022)
88. Sommer F, "The resilience of the intestinal microbiota influences health and disease", Nat Rev Microbiol, 15, pp.630~638 (2017)
89. Martinez C, "Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission", Am J Gastroenterol, 103, pp.643~648 (2008)
90. Lloyd-Price J, "Multiomics of the gut microbial ecosystem in inflammatory bowel diseases", Nature, 569, pp.655~662 (2019)
91. Wang W, "Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease", J Clin Microbiol, 52, pp.398~406 (2014)
92. Liu X, "Blautia-a new functional genus with potential probiotic properties?", Gut Microbes, 13, pp.1~21 (2021)
93. Henke MT, "Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn's disease, produces an inflammatory polysaccharide", Proc Natl Acad Sci U S A, 116, pp.12672~12677 (2019)
94. Lopez-Siles M, "Faecalibacterium prausnitzii : from microbiology to diagnostics and prognostics", ISME J, 11, pp.841~852 (2017)
95. Alam MT, "Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels", Gut Pathog, 12, pp.1~ (2020)
96. Khan I, "Alteration of gut microbiota in inflammatory bowel disease (IBD): cause or consequence? IBD treatment targeting the gut microbiome", Pathogens, 8, pp.126~ (2019)
97. Zhang Z, "Regulatory role of short-chain fatty acids in inflammatory bowel disease", Cell Commun Signal, 20, pp.64~ (2022)
98. Parada Venegas D, "Short chain fatty acids(SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases", Front Immunol, 10, pp.277~ (2019)
99. Hu S, "Inflammation status modulates the effect of host genetic variation on intestinal gene expression in inflammatory bowel disease", Nat Commun, 12, pp.1122~ (2021)
100. Ahlawat S, "Inflammatory bowel disease : tri-directional relationship between microbiota, immune system and intestinal epithelium", Crit Rev Microbiol, 47, pp.254~273 (2021)
101. Goethel A, "Nod2 influences microbial resilience and susceptibility to colitis following antibiotic exposure", Mucosal Immunol, 12, pp.720~732 (2019)
102. Lavelle A, "Gut microbiota-derived metabolites as key actors in inflammatory bowel disease", Nat Rev Gastroenterol Hepatol, 17, pp.223~237 (2020)
103. Sands BE, "Biomarkers of inflammation in inflammatory bowel disease", Gastroenterology, 149, pp.1275~1285 (2015)
104. Nikolaus S, "Increased tryptophan metabolism is associated with activity of inflammatory bowel diseases", Gastroenterology, 153, pp.1504~1516 (2017)
105. Nyström N, "Mucosal and plasma metabolomes in new-onset paediatric inflammatory bowel disease : correlations with disease characteristics and plasma inflammation protein markers", J Crohns Colitis, 17, pp.418~432 (2023)
106. Le Gall G, "Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome", J Proteome Res, 10, pp.4208~4218 (2011)
107. Ottman N, "Genome-scale model and omics analysis of metabolic capacities of Akkermansia muciniphila reveal a preferential mucin-degrading lifestyle", Appl Environ Microbiol, 83, pp.e01014~17 (2017)
108. Seregin SS, "NLRP6 protects Il10-", -mice from colitis by limiting colonization of Akkermansia muciniphila, 2017, pp.19, 733~745
109. Stenman LK, "High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids", World J Gastroenterol, 18, pp.923~929 (2012)
110. Llewellyn SR, "Interactions between diet and the intestinal microbiota alter intestinal permeability and colitis severity in mice", Gastroenterology, 154, pp.1037~1046 (2018)
111. Fritsch J, "Low-fat, high-fiber diet reduces markers of inflammation and dysbiosis and improves quality of life in patients with ulcerative colitis", Clin Gastroenterol Hepatol, 19, pp.1189~1199 (2021)
112. David LA, "Diet rapidly and reproducibly alters the human gut microbiome", Nature, 505, pp.559~563 (2014)
113. Gradel KO, "Increased short-and long-term risk of inflammatory bowel disease after Salmonella or Campylobacter gastroenteritis", Gastroenterology, 137, pp.495~501 (2009)
114. Choi JJ, "Exercise attenuates PCB-induced changes in the mouse gut microbiome", Environ Health Perspect, 121, pp.725~730 (2013)
115. Choi JJ, "Lipopolysaccharide potentiates polychlorinated biphenyl-induced disruption of the blood-brain barrier via TLR4", IRF-3 signaling, 2012, pp.302, 212~220
116. Dethlefsen L, "Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation", Proc Natl Acad Sci U S A, 108(Suppl 1), pp.4554~4561 (2011)
117. Jernberg C, "Long-term ecological impacts of antibiotic administration on the human intestinal microbiota", ISME J, 1, pp.56~66 (2007)
118. Ewaschuk JB, "Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function", Am J Physiol Gastrointest Liver Physiol, 295, pp.G1025~G1034 (2008)
119. Salim SY, "Exposure to ingested airborne pollutant particulate matter increases mucosal exposure to bacteria and induces early onset of inflammation in neonatal IL-10-deficient mice", Inflamm Bowel Dis, 20, pp.1129~1138 (2014)
120. Benjamin JL, "Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota", Inflamm Bowel Dis, 18, pp.1092~1100 (2012)
121. Biedermann L, "Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans", PLoS One, 8, pp.e59260~ (2013)
122. Hoentjen F, "CD4(+)T lymphocytes mediate colitis in HLAB27transgenic rats monoassociated with nonpathogenic Bacteroides vulgatus", Inflamm Bowel Dis, 13, pp.317~324 (2007)
123. Ng SC, "Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease", Inflamm Bowel Dis, 17, pp.2027~2037 (2011)
124. Cai S, "Appendectomy is associated with alteration of human gut bacterial and fungal communities", Front Microbiol, 12, pp.724980~ (2021)
125. Cholapranee A, "Environmental hygiene and risk of inflammatory bowel diseases : a systematic review and meta-analysis", Inflamm Bowel Dis, 22, pp.2191~2199 (2016)
126. Zhou SY, "Microbial flow within an air-phyllosphere-soil continuum", Front Microbiol, 11, pp.615481~ (2020)
127. Debarry J, "Acinetobacter lwoffii and Lactococcus lactis strains isolated from farm cowsheds possess strong allergy-protective properties", J Allergy Clin Immunol, 119, pp.1514~1521 (2007)
128. Fujimura KE, "House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection", Proc Natl Acad Sci U S A, 111, pp.805~810 (2014)
129. Eichele DD, "Dextran sodium sulfate colitis murine model : an indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis", World J Gastroenterol, 23, pp.6016~6029 (2017)
130. Mizoguchi A, "Animal models of inflammatory bowel disease", Prog Mol Biol Transl Sci, 105, pp.263~320 (2012)
131. Bauer C, "Colitis induced in mice with dextran sulfate sodium(DSS)is mediated by the NLRP3 inflammasome", Gut, 59, pp.1192~1199 (2010)
132. Fitzpatrick LR, "IBD and bile acid absorption : focus on pre-clinical and clinical observations", Front Physiol, 11, pp.564~ (2020)
133. Croxford AL, "IL-12-and IL-23 in health and disease", Cytokine Growth Factor Rev, 25, pp.415~421 (2014)
134. Macho Fernandez E, "Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide", Gut, 60, pp.1050~1059 (2011)
135. Cohen LJ, "Genetic factors and the intestinal microbiome guide development of microbe-based therapies for inflammatory bowel diseases", Gastroenterology, 156, pp.2174~2189 (2019)
136. Hu S, "Whole exome sequencing analyses reveal gene-microbiota interactions in the context of IBD", Gut, 70, pp.285~296 (2021)
137. Wirtz S, "Chemically induced mouse models of acute and chronic intestinal inflammation", Nat Protoc, 12, pp.1295~1309 (2017)
138. Katsandegwaza B, "Inflammatory bowel disease : a review of pre-clinical murine models of human disease", Int J Mol Sci, 23, pp.9344~ (2022)
139. Strober W, "Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases", Gastroenterology, 140, pp.1756~1767 (2011)
140. Reinisch W, "Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC : efficacy and safety from a phase IIa randomised multicentre study", Gut, 64, pp.894~900 (2015)
141. Danese S, "Tralokinumab for moderate-to-severe UC : a randomised, double-blind, placebo-controlled, phase IIa study", Gut, 64, pp.243~249 (2015)
142. Ahern PP, "Interleukin-23drives intestinal inflammation through direct activity on T cells", Immunity, 33, pp.279~288 (2010)
143. Harbour SN, "Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis", Proc Natl Acad Sci U S A, 112, pp.7061~7066 (2015)
144. Kwan A, "Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States", JAMA, 312, pp.729~738 (2014)
145. Engelhardt KR, "IL-10 in humans : lessons from the gut, IL-10", IL-10 receptor deficiencies, and IL-10polymorphisms, 2014, pp.380, 1~18
146. Zhu L, "IL-10 and IL-10 receptor mutations in very early onset inflammatory bowel disease", Gastroenterology Res, 10, pp.65~69 (2017)
147. Marlow GJ, "Why interleukin-10supplementation does not work in Crohn's disease patients", World J Gastroenterol, 19, pp.3931~3941 (2013)
148. Carreras-Torres R, "Identifying environmental risk factors for inflammatory bowel diseases : a Mendelian randomization study", Sci Rep, 10, pp.19273~ (2020)
149. Pedersen KM, "Risk of ulcerative colitis and Crohn's disease in smokers lacks causal evidence", Eur J Epidemiol, 37, pp.735~745 (2022)
150. Georgiou AN, "Cigarette smoking, coffee consumption, alcohol intake, and risk of Crohn's disease and ulcerative colitis : a Mendelian randomization study", Inflamm Bowel Dis, 27, pp.162~168 (2021)
151. Saadh MJ, "A Mendelian randomization analysis investigates causal associations between inflammatory bowel diseases and variable risk factors", Nutrients, 15, pp.1202~ (2023)
152. Chen B, "Mendelian randomization analysis reveals causal effects of food intakes on inflammatory bowel disease risk", Front Immunol, 13, pp.911631~ (2022)
153. Kellermayer R, "Colonic mucosal DNA methylation, immune response, and microbiome patterns in Toll-like receptor 2-knockout mice", FASEB J, 25, pp.1449~1460 (2011)
154. Gevers D, "The treatmentnaive microbiome in new-onset Crohn's disease", Cell Host Microbe, 15, pp.382~392 (2014)
155. Chen L, "The role of Th17 cells in inflammatory bowel disease and the research progress", Front Immunol, 13, pp.1055914~ (2022)
156. Liu B, "Two-sample Mendelian randomization analysis investigates causal associations between gut microbial genera and inflammatory bowel disease, and specificity causal associations in ulcerative colitis or Crohn's disease", Front Immunol, 13, pp.921546~ (2022)
157. Zhuang Z, "GWAS-associated bacteria and their metabolites appear to be causally related to the development of inflammatory bowel disease", Eur J Clin Nutr, 76, pp.1024~1030 (2022)
158. Na YR, "Macrophages in intestinal inflammation and resolution : a potential therapeutic target in IBD", Nat Rev Gastroenterol Hepatol, 16, pp.531~543 (2019)
159. Zhang L, "Bacterial species associated with human inflammatory bowel disease and their pathogenic mechanisms", Front Microbiol, 13, pp.801892~ (2022)
160. Henke MT, "Capsular polysaccharide correlates with immune response to the human gut microbe Ruminococcus gnavus", Proc Natl Acad Sci U S A, 118, pp.e2007595118~ (2021)
161. Duerr RH, "Genome-wide association studies herald a new era of rapid discoveries in inflammatory bowel disease research", Gastroenterology, 132, pp.2045~2049 (2007)
162. Zhang YZ, "Inflammatory bowel disease : pathogenesis", World J Gastroenterol, 20, pp.91~99 (2014)
163. McGovern DP, "Genetics of inflammatory bowel diseases", Gastroenterology, 149, pp.1163~1176 (2015)
164. Zuk O, "The mystery of missing heritability : genetic interactions create phantom heritability", Proc Natl Acad Sci U S A, 109, pp.1193~1198 (2012)
165. Stolzer I, "Environmental microbial factors determine the pattern of inflammatory lesions in a murine model of Crohn's disease-like inflammation", Inflamm Bowel Dis, 26, pp.66~79 (2020)
166. Khan S, "Dietary simple sugars alter microbial ecology in the gut and promote colitis in mice", Sci Transl Med, 12, pp.eaay6218~ (2020)
167. Ni J, "Gut microbiota and IBD : causation or correlation?", Nat Rev Gastroenterol Hepatol, 14, pp.573~584 (2017)
168. Albenberg LG, "Diet and the intestinal microbiome : associations, functions, and implications for health and disease", Gastroenterology, 146, pp.1564~1572 (2014)
169. Tanaka S, "High-fat diet-derived free fatty acids impair the intestinal immune system and increase sensitivity to intestinal epithelial damage", Biochem Biophys Res Commun, 522, pp.971~977 (2020)

관련 논문AI추천